RSV-IGIV Therapy: A Cost/Benefit Analysis
- 1 September 1997
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 100 (3) , 417-418
- https://doi.org/10.1542/peds.100.3.417
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants With Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin ProphylaxisPediatrics, 1997
- Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calvesJournal of Virology, 1995
- Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young ChildrenNew England Journal of Medicine, 1993